Marshall Wace’s Akso Health Group AHG Stock Holding History

Marshall Wace’s Portfolio AHG Stock Details AHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,201	Closed	-$14K	–	3287
2021 Q4	$14K	Buy	+8,201	New	+$30.4K	﹤0.01%	3732

Other funds holding AHG

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Marshall Wace's AHG Position: Q1 2022 in Review

Marshall Wace sold out of Akso Health Group (AHG) in Q1 2022, closing a stake of 8,201 shares — an estimated $14K sold.

Marshall Wace first reported a position in AHG in Q4 2021 and held it in 1 quarter. The position peaked at $14K in Q4 2021. 7 funds tracked by Wall St. Rank hold AHG as of Q1 2022.

Marshall Wace reported no remaining Akso Health Group position as of Q1 2022 after selling out during the quarter.
Marshall Wace sold 8,201 Akso Health Group shares in Q1 2022, an estimated $14K.
Marshall Wace first reported a position in Akso Health Group in Q4 2021 and held it in 1 quarter.
Marshall Wace's Akso Health Group position peaked at $14K in Q4 2021.
7 funds tracked by Wall St. Rank held Akso Health Group as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.